Mitochondrial Profiling of Acute Myeloid Leukemia in the Assessment of Response to Apoptosis Modulating Drugs | PLOS ONE
Genetic variants in acute myeloid leukemia (AML) cell lines. | Download Scientific Diagram
The LL-100 panel: 100 cell lines for blood cancer studies | Scientific Reports
Targeting an RNA-Binding Protein Network in Acute Myeloid Leukemia - ScienceDirect
Acute myeloid leukemia (AML) cell lines and patient samples | Download Table
Cells | Free Full-Text | Scalable Enrichment of Immunomodulatory Human Acute Myeloid Leukemia Cell Line-Derived Extracellular Vesicles
Leukaemia cell of origin identified by chromatin landscape of bulk tumour cells | Nature Communications
The gene mutation landscape of acute myeloid leukemia cell lines and its exemplar use to study the BCOR tumor suppressor | Leukemia
Frontiers | Emvododstat, a Potent Dihydroorotate Dehydrogenase Inhibitor, Is Effective in Preclinical Models of Acute Myeloid Leukemia
An Advanced Preclinical Mouse Model for Acute Myeloid Leukemia Using Patients' Cells of Various Genetic Subgroups and In Vivo Bioluminescence Imaging | PLOS ONE
IJMS | Free Full-Text | Choosing the Right Cell Line for Acute Myeloid Leukemia (AML) Research
Frontiers | Macrophages in Acute Myeloid Leukaemia: Significant Players in Therapy Resistance and Patient Outcomes
Acute myeloid leukemia - Wikipedia
Combinatorial targeting of XPO1 and FLT3 exerts synergistic anti-leukemia effects through induction of differentiation and apoptosis in FLT3-mutated acute myeloid leukemias: from concept to clinical trial | Haematologica
AML cell lines used in this study | Download Table
A Novel Application of Furazolidone: Anti-Leukemic Activity in Acute Myeloid Leukemia | PLOS ONE
Table 2 from Establishment of a human acute myeloid leukemia cell line (Kasumi-1) with 8;21 chromosome translocation. | Semantic Scholar
TP53 mutations and drug sensitivity in acute myeloid leukaemia cells with acquired MDM2 inhibitor resistance | bioRxiv
TARP is an immunotherapeutic target in acute myeloid leukemia expressed in the leukemic stem cell compartment | Haematologica
Follistatin is a novel therapeutic target and biomarker in FLT3/ITD acute myeloid leukemia | EMBO Molecular Medicine
